|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV050286765 |
| 003 |
DE-627 |
| 005 |
20230624163537.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
200625s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.pcd.2019.11.004
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001009.pica
|
| 035 |
|
|
|a (DE-627)ELV050286765
|
| 035 |
|
|
|a (ELSEVIER)S1751-9918(19)30439-5
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 630
|q VZ
|
| 082 |
0 |
4 |
|a 640
|q VZ
|
| 082 |
0 |
4 |
|a 590
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 600
|q VZ
|
| 084 |
|
|
|a 50.70
|2 bkl
|
| 100 |
1 |
|
|a Caldeira, Daniel
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis
|
| 264 |
|
1 |
|c 2020
|
| 300 |
|
|
|a 9
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a • Aspirin modestly reduces major adverse cardiovascular events risk. • Aspirin does not reduce all-cause mortality risk. • Aspirin does increase the risk of major bleeding risk. • Aspirin prescription in primary prevention in diabetics must be individualized.
|
| 650 |
|
7 |
|a Net clinical benefit
|2 Elsevier
|
| 650 |
|
7 |
|a Antiplatelet
|2 Elsevier
|
| 650 |
|
7 |
|a Primary prevention
|2 Elsevier
|
| 650 |
|
7 |
|a Diabetes mellitus
|2 Elsevier
|
| 650 |
|
7 |
|a Peripheral arterial disease
|2 Elsevier
|
| 650 |
|
7 |
|a Cardiovascular disease
|2 Elsevier
|
| 650 |
|
7 |
|a Coronary disease
|2 Elsevier
|
| 650 |
|
7 |
|a Cerebrovascular disease
|2 Elsevier
|
| 650 |
|
7 |
|a Revascularization
|2 Elsevier
|
| 700 |
1 |
|
|a Alves, Mariana
|4 oth
|
| 700 |
1 |
|
|a David, Cláudio
|4 oth
|
| 700 |
1 |
|
|a Costa, João
|4 oth
|
| 700 |
1 |
|
|a Ferreira, Joaquim J.
|4 oth
|
| 700 |
1 |
|
|a Pinto, Fausto J.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
| 773 |
1 |
8 |
|g volume:14
|g year:2020
|g number:3
|g pages:213-221
|g extent:9
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2019.11.004
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 14
|j 2020
|e 3
|h 213-221
|g 9
|